---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-093114"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T11:16:57.463406+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q2 revenue up 20% to $312M; raises FY2024 guidance on strong margins

## Summary
- Revenue $312.3M (+20% YoY); net loss narrowed to $23.3M from $45.5M; Adjusted EBITDA $28.6M (+103%).
- Center Margin improved to 31.3% of revenue (28.1% prior year); clinician base up 14% to 6,984.
- FY2024 guidance raised: revenue $1.2B-$1.242B, Adjusted EBITDA $90M-$100M; expects positive free cash flow.
- Q3 2024 guidance: revenue $290M-$310M, Adjusted EBITDA $15M-$21M.
- Cash $87M, net debt $279.5M; operating cash flow $44.1M in Q2.

## SEC filing metadata
- accession: 0000950170-24-093114
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017024093114/0000950170-24-093114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017024093114/lfst-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-093114
- JSON: https://secwatch.observer/filing/0000950170-24-093114.json
- Plain text: https://secwatch.observer/filing/0000950170-24-093114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.